Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acetaminophen hepatotoxicity.

Matthew Q Bromer1, Martin Black

  • 1Abdominal Organ Transplantation Program, Division of Gastroenterology, Temple University School of Medicine, Philadelphia, PA 19140, USA.

Clinics in Liver Disease
|July 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasound shear wave elastography - a reliable protocol for the assessment of the stiffness of the supraspinatus tendon.

Shoulder & elbow·2025
Same author

Genetic predisposition to depression and inflammation impacts symptom burden and survival in patients with head and neck cancer: A longitudinal study.

Journal of affective disorders·2023
Same author

Biopsychosocial Markers of Body Image Concerns in Patients with Head and Neck Cancer: A Prospective Longitudinal Study.

Current oncology (Toronto, Ont.)·2022
Same author

Establishment Of Virtual Fracture Clinic In Princess Royal Hospital Telford: Experience And Recommendations During The First 9 Months.

Journal of Ayub Medical College, Abbottabad : JAMC·2022
Same author

Body Image Concerns in Patients With Head and Neck Cancer: A Longitudinal Study.

Frontiers in psychology·2022
Same author

Psychosocial outcomes of human papillomavirus (HPV)- and non-HPV-related head and neck cancers: A longitudinal study.

Psycho-oncology·2022
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Acetaminophen, a common over-the-counter drug, poses a higher risk of severe liver injury than other medications. Despite international controls, the United States has not regulated its distribution, leading to significant public health concerns.

Area of Science:

  • Hepatology
  • Pharmacology
  • Toxicology

Background:

  • Acetaminophen is a widely available over-the-counter medication.
  • Unlike prescription drugs, its accessibility in drug stores and supermarkets bypasses physician oversight.
  • Concerns exist regarding the potential for severe liver injury associated with its use.

Purpose of the Study:

  • To highlight the significant risk of liver injury from acetaminophen compared to other drugs.
  • To examine the regulatory approaches to acetaminophen in the United States versus Europe.
  • To advocate for increased regulation of acetaminophen marketing and distribution.

Main Methods:

  • Comparative analysis of drug-induced liver injury data.
  • Review of regulatory actions concerning acetaminophen in different regions.

Related Experiment Videos

  • Assessment of Food and Drug Administration (FDA) stance on acetaminophen control.

    • Main Results:

    • Acetaminophen use is associated with a higher likelihood of severe liver injury or death compared to other medications studied.
    • Regulatory measures to control acetaminophen quantity have been implemented in Europe but not in the United States.
    • The FDA has expressed concern but has not yet enacted stricter regulations.

    Conclusions:

    • Acetaminophen represents a significant public health risk due to its accessibility and potential for severe hepatotoxicity.
    • The lack of stringent regulation in the US contrasts with European efforts and warrants urgent attention.
    • Further regulatory action is needed to mitigate acetaminophen-related liver injury.